Multiple sclerosis (MS) is a debilitating autoimmune disease affecting over 2.3 million
people worldwide, and it is characterized by inflammation and demyelination of nerve cells …

The short non-coding microRNAs (miRNAs) have emerged as reliable modulators of various
pathological conditions including autoimmune diseases in mammals. The current study …

MicroRNA (miRNA) are small non-coding RNA molecules about 21–25 nucleotides long.
They control gene regulation by translational repression and cleavage. Several studies have …

Background MicroRNAs (miRNAs) regulate gene expression post-transcriptionally via
mRNA degradation. As a result, they have an impact on a variety of pathways in organisms …

Multiple Sclerosis (MS) is an autoimmune condition caused by chronic inflammation of
central nervous system and demyelination of neurons. At present, microRNAs (miRNAs) are …

Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system
characterized by chronic inflammation, demyelination, and axonal damage. As microRNA …

Multiple sclerosis is an autoimmune neurodegenerative disease of the central nervous
system characterized by pronounced inflammatory infiltrates entering the brain, spinal cord …

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system
(CNS) characterized by demyelination and axonal degeneration. Abnormal expression of …

Identification of novel targets and biomarkers, such as microRNAs, is extremely helpful to
understand the pathogenetic mechanisms in a disease like multiple sclerosis (MS). We …

OBJECTIVE: miRNAs are key reg-ulators in multiple sclerosis. To gain a better
understanding of the molecular mechanisms of multiple sclerosis, differentially expressed …